Amazon Launches National Weight-Loss Care Program

Getting access to popular weight-loss drugs just became safer and easier for millions of Americans.

Amazon's One Medical announced Tuesday it's launching a nationwide program that combines GLP-1 medications like Ozempic and Wegovy with ongoing primary care support. The service is now available at over 200 offices across more than 20 cities, including Chicago, Miami, and San Francisco.

The timing matters. As demand for these drugs explodes, doctors are seeing troubling gaps in care. One Medical executives told reporters some patients are arriving from other providers malnourished or on dangerous doses because they weren't properly monitored.

The new program works differently than many telehealth options that simply prescribe pills. Patients get regular check-ins, lab work, and monitoring from clinicians who also manage related conditions like diabetes and high blood pressure. They can visit offices in person or connect virtually, depending on what they need.

Dr. Hemalee Patel, senior medical director at One Medical, says treating weight loss separately from overall health misses the bigger picture. The program focuses on nutrition, lifestyle changes, and managing side effects alongside medication adjustments.

Cost has been a major barrier for many people interested in these drugs. Through Amazon Pharmacy, patients with insurance can access GLP-1 medications for as little as $25 monthly. Cash prices start around $149 for pills and $299 for injectables, with upfront pricing so there are no surprises.

The Ripple Effect

Amazon's entry into comprehensive weight-loss care could reshape how patients access these life-changing medications. Just days earlier, Walmart unveiled its own GLP-1 platform, signaling that major retailers see an opportunity to fill critical gaps left by fragmented telehealth services.

The broader impact goes beyond convenience. Better integrated care means fewer patients experiencing dangerous side effects or abandoning treatment. It also sets a new standard for how weight-loss medications should be prescribed and monitored.

New oral versions of these drugs could soon attract people hesitant about injections. Expanded Medicare coverage and additional approved uses are expected to bring treatment within reach for even more Americans struggling with obesity and related health conditions.

Millions of people who felt their options were limited to sketchy online prescriptions or going without now have a pathway to safe, comprehensive care.